Paratek

mycobacteria (NTM) OMG!

 

Anyone know the salary for institutional sales rep? These are Paratek jobs, not contract Amplity jobs, right? I’d like to get out of primary care and get some specialty experience

 

175K with 20,000 stock options

 

I am going to wait till it goes to “0” then buy

 

Should be 0 soon under the brilliant leadership of the clowns here. AW and CC are clueless.

 

CC sure is cute!

 

It is hard to get a straight answer on salary because recruiting is being done by the SLIM RECRUITERS that work at Amplity (aka Publicis).

 

how many red flags do you need?

 

All of these comments are spot on. Horrible work environment, terrible marketing, cocky, arrogant, micro-management. Amplity should be embarrassed for taking this mess on as a client.

 

What a mess. Pathetic.

 

is hiring complete?

 

have they hired KAMs?

 

Whistle blowers gonna make some $$$$$.

 

The earnings call sure painted a rosy picture. We only lost 32 million! The high formulary rejection rate and the fact that almost no hospitals have added it to formulary or protocols was not discussed.
How are we supposed to get CABP business if hospitals have rejected Nuzyra in favor of the less expensive and efficacious Xerava, Xenleta, tiggy, and moxi? How is it going to get started for CABP if it’s not stocked because it’s not on formulary?
Apparently we are expected to do 4 million this quarter? How? The answer is to recertify and make more calls!!!!
(And by the way, it’s pronounced “in·vuhn·taw·ree” not “in•ven•tree”)

 

NTM

 

Have a phone screen with hr Monday at 2 for this company but now I’m feeling like canceling that......anyone actually work there that’s been replying to the forum? Of course everyone that left is going to leave bad comments. Thanks in advance.

 

Did Loh write that last post? Lol

“Paratek says its new antibiotic Nuzyra treats pneumonia and skin infections with fewer toxic side effects, but it's been a tough sell at many hospitals, where budgets are tight and federal Medicare reimbursements for antibiotics are low.

"Payers and hospitals have said, you know, 'we have our generics, we need to control our costs … we'll just go ahead with the older antibiotics that we have here today.' They're telling us they don't want our innovation," Loh said.”

https://www.cbsnews.com/news/drug-resistant-infections-new-antibiotics-needed-high-cost-preventing-development/

 

https://www.cbsnews.com/news/drug-resistant-infections-new-antibiotics-needed-high-cost-preventing-development/

“Paratek says its new antibiotic Nuzyra treats pneumonia and skin infections with fewer toxic side effects, but it's been a tough sell at many hospitals, where budgets are tight and federal Medicare reimbursements for antibiotics are low.

"Payers and hospitals have said, you know, 'we have our generics, we need to control our costs … we'll just go ahead with the older antibiotics that we have here today.' They're telling us they don't want our innovation," Loh said.”

Maybe Loh wrote the previous post!!!

 

Ask recruiter about all the role playing.
we had a 2 1/2 hour conference call on messaging and had to verbalize the message on call. Funny stuff!

 

Bankruptcy on the horizon.

https://www.beckershospitalreview.com/pharmacy/31-drugmakers-at-high-risk-for-bankruptcy-in-2020.html?oly_enc_id=5134C2799901E6Y